Organogenesis Holdings (ORGO) Net Cash Flow (QoQ) (2016 - 2026)
Organogenesis Holdings (ORGO) Net Cash Flow (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Organogenesis Holdings | 241.91 Mn | 195.06 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,927.55% |
| Mar 31, 2026 | -107.45% |
| Dec 31, 2025 | 419.97% |
| Sep 30, 2025 | 74.56% |
| Jun 30, 2025 | -43.65% |
| Mar 31, 2025 | -162.14% |
| Dec 31, 2024 | 826.61% |
| Sep 30, 2024 | 293.37% |
| Jun 30, 2024 | 107.54% |
| Mar 31, 2024 | -371.94% |
| Dec 31, 2023 | -40.83% |
| Sep 30, 2023 | 9,918.28% |
| Jun 30, 2023 | 100.67% |
| Mar 31, 2023 | -193.28% |
| Dec 31, 2022 | 3.90% |
| Sep 30, 2022 | -210.83% |
| Jun 30, 2022 | 173.71% |
| Mar 31, 2022 | -151.05% |
| Dec 31, 2021 | -4.94% |
| Sep 30, 2021 | 0.55% |